Viatris

Viatris Equity

The The Equity of Viatris (VTRS) as of Nov 12, 2026 is 14.71 B USD. In the previous year, The Equity was 18.64 B USD — a change of -21.06% (lower).

Equity

14.71 BUSD

YoY

-21.06%

Last updated:

In 2025, Viatris's equity was 14.71 B USD, a -21.06% increase from the 18.64 B USD equity in the previous year.

The Viatris Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
12.17 B USD
Jan 1, 2019
11.88 B USD
Jan 1, 2020
22.95 B USD
Jan 1, 2021
20.49 B USD
Jan 1, 2022
21.07 B USD
Jan 1, 2023
20.47 B USD
Jan 1, 2024
18.64 B USD
Jan 1, 2025
14.71 B USD
The Viatris Equity history
YEAREquityYoY
14.71 BUSD-21.06%
18.64 BUSD-8.95%
20.47 BUSD-2.87%
21.07 BUSD+2.83%
20.49 BUSD-10.72%
22.95 BUSD+93.15%
11.88 BUSD-2.33%
12.17 BUSD-8.57%
13.31 BUSD+19.71%
11.12 BUSD+13.84%
9.76 BUSD+199.90%
3.26 BUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Viatris Stock analysis

What does Viatris do? Viatris Inc. is a global pharmaceutical company that was formed in 2020 through the merger of Mylan and Upjohn. Headquartered in Pennsylvania, USA, the company operates in over 165 countries. Viatris is one of the largest generic and biosimilar manufacturers worldwide. Viatris is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Viatris's Equity

Viatris's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Viatris's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Viatris's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Viatris's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Viatris’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Viatris stock

The Equity of Viatris is 14.71 B USD in 2025.

The Equity of Viatris changed from 18.64 B USD to 14.71 B USD, representing a -21.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Viatris since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Viatris historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Viatris

All Key Metrics — Viatris